PS targeting was never more than a pipedream. If anything it is an effect no a cause and thus might have some value as a dianostic not a therapeutic ( if you could even develop a therapeutic to it which Bavi certainly was not). Haven't checked in on this sad stock in a long time but it's good to see some things never change!
News 
Market Data 
Discover 
